Cambridge Antibody Technology and Lonza extend Manufacturing Agreement
20-Jan-2004
The agreement, which is effective immediately, will guarantee that CAT and its collaborators have access to Lonza's manufacturing capability at production scale (up to 2,000L) for both ongoing programmes and future projects.
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.